期刊文献+

体外系统性评价79种中药注射剂对9种人细胞色素P450酶的抑制作用 被引量:2

In vitro inhibition by 79 herb injectables of nine human cytochrome P450 isoenzymes:a systematic evaluation of herb-drug interactions
原文传递
导出
摘要 中药注射剂在临床经常与化学药物联用治疗多种复杂疾病,但其中药-药物的相互作用还没有得到充分的研究,有时甚至被临床忽视。本文研究国家食品药品监督管理局批准的79种中药注射剂,评价它们对人体药物代谢酶-细胞色素P450(CYP450)的潜在抑制作用。使用9种人CYP450s(包括CYP1A、CYP2A6、CYP2B6、CYP2C8、CYP2C9、CYP2C19、CYP2D6、CYP2E1和CYP3A)、特异性底物和中药注射剂共同孵育,使用灵敏度、准确度高的液相串联质谱(LC-MS/MS)对探针形成的代谢产物进行定量分析,评价79种中药注射剂对CYP450的体外抑制作用。在79种中药注射液中,当在中药注射液5%(v/v)和注射用粉针剂2倍日最大使用剂量换算浓度CMDD(mg·mL-1)筛选时有37种中药注射剂对CYP1A、24种中药注射剂对CYP2A6、41种中药注射剂对CYP2B6、36种中药注射剂对CYP2C9、41种中药注射剂对CYP2C19、41种中药注射剂对CYP2D6、25种中药注射剂对CYP2E1和42种中药注射剂对CYP3A表现出50%的抑制率或更强的抑制作用。在预孵育或与人肝微粒体共孵育30 min后,观察到2种中药注射剂对CYP1A、5种中药注射剂对CYP2A6、5种中药注射剂对CYP2B6、6种中药注射剂对CYP2C8、1种中药注射剂对CYP2D6、6种中药注射剂对CYP3A呈现时间依赖性抑制(TDI)作用。结果表明,中药注射剂存在基于CYP450的中药-药物相互作用及时间依赖性的中药-药物相互作用,需要临床医生用药提高警惕。 Seventy-nine injectable herb extractions have been approved by the Chinese Food and Drug Administration(CFDA)and are frequently administered intravenously for various diseases.Unfortunately,herb-drug interactions are under-investigated and sometimes overlooked in the clinic.In the present investigation the in vitro inhibition of 9 drug metabolizing enzymes including CYP1A,CYP2A6,CYP2B6,CYP2C8,CYP2C9,CYP2C19,CYP2D6,CYP2E1,and CYP3A was assessed using an appropriate probe substrate for each enzyme with human liver microsomes.Metabolite formation was quantified using a validated and sensitive high-performance liquid chromatography-tandem mass spectrometry(LC-MS/MS)assay.The IC50 of each herb extract was estimated using a concentration range from 5%to 0.5%,and the time-dependent inhibition of the nine CYP450 isoenzymes was also determined.Of the 79 approved iv herb injectables,37 inhibited CYP1A,24 inhibited CYP2A6,41 inhibited CYP2B6,36 inhibited CYP2C8,31 inhibited CYP2C9,41 inhibited CYP2C19,13 inhibited CYP2D6,25 inhibited CYP2E1,and 42 inhibited CYP3A with 50%or greater inhibition at a test concentration of 5%(v/v).IC50 differences were noted between pre-incubation or co-incubation assays with HLM for 30 min,with the time-dependent inhibitory(TDI)effects were observed with 2 injectables on CYP1A,5 injectables on CYP2A6,5 injectables on CYP2B6,6 injectables on CYP2C8,1 injectable on CYP2D6 and 6 injectables on CYP3A.Collectively,the results demonstrate that potential herb-drug interactions(HDIs)can occur with the concomitant use of herb injectables and prescription drugs that are cleared by CYP450 enzymes,and further investigation is warrant for the clinical relevance of these interactions.
作者 姜波 石美智 陈君君 杨姣 张科之 郭澄 韩永龙 JIANG Bo;SHI Mei-zhi;CHEN Jun-jun;YANG Jiao;ZHANG Ke-zhi;GUO Cheng;HAN Yong-long(Department of Pharmacy,Shanghai Jiaotong University Affiliated Sixth People's Hospital,Shanghai 200233,China;KG Pharma Limited,Foshan 528000,China)
出处 《药学学报》 CAS CSCD 北大核心 2021年第1期274-282,共9页 Acta Pharmaceutica Sinica
基金 国家自然科学基金面上项目(81773949) 上海市浦东新区科技发展基金民生科研专项资金医疗卫生项目(PKJ2017-Y07、PKJ2019-Y04) 上海市浦东新区卫生和计划生育委员会科研项目(PW2017E-2) 上海市卫生和计划生育委员会科研项目(20174Y0023) 上海健康医学院师资人才百人库项目(B3-0200-20-311008-02).
关键词 中药注射剂 细胞色素P450 抑制作用 中药-药物相互作用 herb extract injectables cytochrome P450 inhibition herb-drug interaction
  • 相关文献

参考文献9

二级参考文献110

  • 1刘燕,李振洲,曹燕滔,王文妍.疏血通注射液和华法林联用致国际标准化比率升高[J].药物不良反应杂志,2007,9(3):217-218. 被引量:6
  • 2中华人民共和国卫生部药品标准[S].中药成方制剂.第14册,1995,WS3-B-2752-97.
  • 3WIENKERS LC, HEATH TG. Predicting in vivo drug interactions from in vitro drug discovery data [J]. Nat Rev Drug Discov, 2005, 4(10) : 825-833.
  • 4MUKADAM S, TAY S, TRAN D, et al. Evaluation of time- dependent cytochrome p450 inhibition in a high throughput, automated assay: introducing a novel area under the crone shit- approach[J]. Drug Metab Lett, 2012, 6(1 ): 43-53.
  • 5ZHOU S, CHAN E, LIM LY, et al. Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4 [J]. Curr Drug Metab, 2004, 5(5): 415-442.
  • 6ZHOU S, YUAN CHAN S, CHER GOH B, et al. Mechanism- based inhibition of cytochrome P450 3A4 by therapeutic drugs[J]. Clin Pharmacolinet, 2005, 44(3): 279-304.
  • 7VANDENBRINK BM, ISOHERRANEN N. The role of metabolites in predicting drug- drug interactions: hecus on irreversible cytochrome P450 inhibition [J]. Curr Opin Drug Discov Devel, 2010, 13(1): 66-77.
  • 8KALGUTKAR AS, OBACH RS, MAURER TS. Mechanism- based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug- drug interactions and idiosyncratic adverse drug reactions[J]. Curr Drug Metab, 2007, 8(5) : 407-447.
  • 9ORR ST, RIPP SL, BALLARD TE, et al. Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure activity relationships and discovery strategies to mitigate drug drug interaction risks[J]. J Med Chem, 2012, 55 (11): 4896- 4933.
  • 10LI AP. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity[J]. Chem Biol Interact, 2002, 142(1-2): 7-23.

共引文献123

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部